Egnyte Announces New Offering Providing Early-Stage Life Science Startups a Year of Egnyte’s Platform at No Cost
Modernizing Infrastructure and Creating Secure Collaboration for Their Global Organization
MOUNTAIN VIEW, Calif., January 5, 2023
Egnyte, the secure platform for content collaboration and governance, recently announced it will be providing early-stage life sciences innovators complimentary access to their award-winning Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform to help them scale and optimize their business, collaborate across their partner ecosystems, and manage risk and regulatory compliance.
“More than ever, agility, speed and collaboration must become core competencies for every life sciences startup,” said Ronen Vengosh, vice president of Life Sciences at Egnyte. “Egnyte is proud to make our cloud-based data and document collaboration solutions even more widely available to the companies who are pioneering the next generation of treatments that will positively improve people’s lives.”
The Egnyte for Life Sciences platform enables pre-clinical and clinical-stage biotechs with limited IT resources to collaborate seamlessly on diverse data sets with their partner ecosystems, while maintaining the required levels of data control and compliance with industry regulations.
“Egnyte’s platform provides a reliable and secure collaboration environment that supports our current data management needs. It's easy to use and can scale with us as our team grows,” said Joe Hunter, M.S., co-founder and co-CEO of VaxSyna. “As we proceed through pre-clinical trials and move to clinical trials, we have peace of mind knowing Egnyte's cloud-based data and document collaboration platform meets regulatory requirements and will grow with us as we continue to focus on tackling global health challenges with our novel vaccine platform.”
Egnyte’s free offering is available exclusively to early-stage life sciences startups. Companies who qualify for the offer will receive 12 months of access to the platform for up to five users. For more information about the offer, click here.
Egnyte for Life Sciences allows companies to securely share and integrate data across their ecosystem of internal and external collaborators in real time. Unlike consumer-grade cloud content sharing applications, the platform provides built-in controls to maintain the quality and integrity of data over its lifecycle. The platform integrates with business and life science applications including Microsoft Office, Google, AWS, and ELNs and provides a solution for secure data collection from sites and partners. Egnyte’s Life Science platform is a fully validated, audit-ready environment compliant with 21 CFR Part 11 for regulated and unregulated data.